Alkermes Plc
ALKS
$40.98-2.73%
End of day · as of Sep 24, 2026, 4:01 PM ET
Mkt cap
$4.78B
EV/Sales
2.98
P/E ratio
N/A
FY2025 Revenue
$1.48B
EPS (TTM)
$0.38
Gross Margin (FY2025)
86.69%
Profit Margin (FY2025)
16.37%
Beta
0.42
Div yield
N/A
Sector
Healthcare
Alkermes Plc (ALKS) is a drug manufacturers - specialty & generic company listed on US.
Latest reported ALKS revenue for 2025-12-31 was $1.48B. Net income was $241.7M. Revenue was down 5.2% from 2024-12-31 to 2025-12-31. ALKS currently screens at market cap $4.78B.
Use this ALKS research hub for sector, financials, and filings — not a live tape.
Latest cached year on this hub. Full ALKS income, balance, and cash tables.
Alkermes Plc (ALKS) is a drug manufacturers - specialty & generic company in the Healthcare sector.
Latest cached Alkermes Plc (ALKS) revenue for Dec 31, 2025 was $1.48B. Net income was $241.7M. Statements: https://lician.com/financials/alks
Alkermes Plc (ALKS) market capitalization is $4.78B on the latest cached snapshot.
Alkermes Plc (ALKS) cached previous close $42.13; day range $40.59 – $42.08; volume 1,882,592. Session quote: https://lician.com/quote/alks
Alkermes Plc (ALKS) latest cached earnings event is "ALKS earnings" on Aug 4, 2026. Earnings calendar: https://lician.com/earnings
The latest cached ALKS filing is 8-K · Sep 21, 2026. Filings: https://lician.com/sec/alks